Regent Investment Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,000
| Closed | -$17K | – | 191 |
|
|
2020
Q2 | $17K | Hold |
20,000
| – | – | 0.01% | 185 |
|
|
2020
Q1 | $17K | Hold |
20,000
| – | – | 0.01% | 178 |
|
|
2019
Q4 | $18K | Hold |
20,000
| – | – | 0.01% | 208 |
|
|
2019
Q3 | $20K | Hold |
20,000
| – | – | 0.01% | 204 |
|
|
2019
Q2 | $22K | Hold |
20,000
| – | – | 0.01% | 205 |
|
|
2019
Q1 | $26K | Hold |
20,000
| – | – | 0.01% | 206 |
|
|
2018
Q4 | $18K | Sell |
20,000
-5,718
| -22% | -$5.15K | 0.01% | 195 |
|
|
2018
Q3 | $53K | Hold |
25,718
| – | – | 0.02% | 203 |
|
|
2018
Q2 | $46K | Hold |
25,718
| – | – | 0.02% | 199 |
|
|
2018
Q1 | $61K | Hold |
25,718
| – | – | 0.02% | 204 |
|
|
2017
Q4 | $48K | Hold |
25,718
| – | – | 0.02% | 205 |
|
|
2017
Q3 | $64K | Hold |
25,718
| – | – | 0.02% | 207 |
|
|
2017
Q2 | $71K | Buy |
25,718
+11,430
| +80% | +$31.6K | 0.03% | 207 |
|
|
2017
Q1 | $43K | Hold |
14,288
| – | – | 0.02% | 199 |
|
|
2016
Q4 | $45K | Buy |
14,288
+2,858
| +25% | +$9K | 0.02% | 181 |
|
|
2016
Q3 | $39K | Buy |
+11,430
| New | +$39K | 0.02% | 181 |
|